Assessing the Use of Certolizumab Pegol in Adult Subjects With Rheumatoid Arthritis on the Antibody Response When Receiving Influenza Virus and Pneumococcal Vaccines
Clinical trial NCT00993668 · COMPLETED
Trial details
- NCT number
- NCT00993668
- Sponsor
- UCB Pharma
- Status
- COMPLETED
- Phase
- Phase 4
- Study type
- INTERVENTIONAL
- Start date
- 2009-09-01
- Primary completion
- 2010-06-01
- Enrollment
- 224
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.